Control of Taenia solium taeniasis/cysticercosis: past practices and new possibilities.
Neurocysticercosis continues to be a major health burden on humans living in many regions of the world, despite the availability of highly effective taeniacides and identification of the cause, Taenia solium, as being potentially eradicable. Several T. solium control trials have been undertaken, generally achieving limited success and none that has been fully documented has achieved what was demonstrated to be a sustainable level of disease control. Pigs act as intermediate hosts for T. solium and two new control tools have become available for application in pigs - single-dose oxfendazole treatment of porcine cysticercosis and the TSOL18 vaccine. Three potential intervention scenarios for pigs are compared for control of cysticercosis, using either oxfendazole or vaccination. A control scenario involving vaccination plus oxfendazole treatment delivered at 4 monthly intervals was predicted to achieve the best outcome, with no pigs slaughtered at 12 months of age having viable T. solium cysticerci. Now that new control tools are available, there are opportunities to concentrate research attention on evaluation of novel control scenarios leading to the implementation of effective and sustainable control programmes and a reduction in the global burden of neurocysticercosis.
Department of Veterinary Science, The University of Melbourne, 250 Princes Highway, Werribee, Victoria 3030, Australia.
Marshall W
MW
Lightowlers
D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use; D000947:Antigens, Helminth / Q000276:immunology; D001562:Benzimidazoles / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003140:Communicable Disease Control / Q000379:methods* / Q000458:organization & administration; D006801:Humans; D020019:Neurocysticercosis / Q000188:drug therapy / Q000276:immunology / Q000517:prevention & control* / Q000662:veterinary*; D013552:Swine; D013553:Swine Diseases / Q000188:drug therapy / Q000276:immunology / Q000517:prevention & control* / Q000635:transmission; D041201:Taenia solium / Q000187:drug effects / Q000276:immunology; D014611:Vaccination; D014612:Vaccines / Q000008:administration & dosage* / Q000276:immunology
D000871:Anthelmintics; D000947:Antigens, Helminth; D001562:Benzimidazoles; D014612:Vaccines; C011030:oxfendazole